Skip to main content
ESMO Open logoLink to ESMO Open
. 2020 Jan 7;5(1):e000599corr1. doi: 10.1136/esmoopen-2019-000599corr1

Correction: Tumour location and efficacy of first-line EGFR inhibitors in KRAS/RAS wild-type metastatic colorectal cancer: retrospective analyses of two phase II randomised Spanish TTD trials

PMCID: PMC7003375  PMID: 31958286

Benavides M, Díaz-Rubio E, Carrato. A On behalf of Spanish Cooperative Group for the Treatment of Digestive Tumours, et alTumour location and efficacy of first-line EGFR inhibitors in KRAS/RAS wild-type metastatic colorectal cancer: retrospective analyses of two phase II randomised Spanish TTD trials. ESMO Open 2019;4:e000599.

‘Author Affiliation’ of Dr. Enrique Aranda was listed incorrectly in the published paper. The correct affiliation is as follows:

“Medical Oncology Service, Hospital Universitario Reina Sofía, Cordoba, Spain”

RESOURCES